Stories
NuSynth Secures Seed Funding to Revolutionize Chemical Processes Using AI
C
CNBC TV18•14-10-2026, 09:40
NuSynth Secures Seed Funding to Revolutionize Chemical Processes Using AI
- •Bengaluru-based NuSynth Technologies raised ₹36.5 crore in a seed funding round co-led by Avaana Capital and Shastra VC.
- •The startup is building an AI-enabled platform to redesign chemical synthesis routes, focusing initially on pharmaceuticals and electronics chemicals.
- •Funds will be used to develop proprietary chemical manufacturing processes, strengthen R&D capabilities, scale up operations, and expand the team.
- •NuSynth aims to address challenges in critical molecule manufacturing such as high material and energy costs, imported intermediates, and hazardous reagents.
- •The founding team includes industry expert Poorvank Purohit and PhD holder Ramesha A R from the Indian Institute of Science.
Key Questions Answered
NuSynth recently raised ₹36.5 crore, which is around $4 million, in a seed funding round co-led by Avaana Capital and Shastra VC.
NuSynth is building an AI-enabled platform to redesign chemical synthesis routes with an initial focus on pharmaceuticals and electronics chemicals. The platform aims to reduce manufacturing costs, improve yields, and enhance commercial-scale production efficiency.
NuSynth's founding team includes Poorvank Purohit, who has experience in the pharmaceutical industry, and Ramesha A R, who holds a PhD from the Indian Institute of Science and conducted postdoctoral research at the National Institutes of Health.
